Downregulation of TGF-β1 gene expression in anterior pituitary cells treated with forskolin

Cytokine

Volumn 9, Issue 2, 1997, Pages 106-111

  Pastorcic, Martine ^a   Sarkar, Dipak K ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Forskolin; Lactotropes; Prolactin; Transforming growth factor 1 gene expression

Indexed keywords

CYCLIC AMP; FORSKOLIN; MESSENGER RNA; PROLACTIN; TRANSFORMING GROWTH FACTOR BETA1;

ADENOHYPOPHYSIS; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL FUNCTION; CELL GROWTH; CONTROLLED STUDY; CULTURE MEDIUM; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HYPOPHYSIS CELL; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSCRIPTION INITIATION;

EID: 0031081642     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1996.0143     Document Type: Article

References (39)

1. 1. Ben-Jonathan N (1985) Dopamine, a prolactin inhibiting hormone. Endocrinol Rev 6:564-589.
2. 2. Lamberts SWJ, Macleod RM (1990) Regulation of prolactin secretion at the level of the lactotroph. Physiol Rev 70:279-318.
3. 3. Maurer RA (1980) Dopaminergic inhibition of prolactin synthesis and prolactin mRNA accumulation in cultured pituitary cells. J Biol Chem 255:8092-8097.
4. 4. Maurer RA (1981) Transcription regulation of the prolactin gene by ergocryptine and cAMP. Nature (Lond) 294:94-97.
5. 5. Pawlikowski I, Kunert-Radek J, Stepien H (1978) Direct antiproliferative effects of dopamine agonists on the anterior pituitary gland in organ culture. J Endocrinol 79:245-246.
6. 6. Lloyd HM, Meares, JD, Jacobi J (1975) Effects of estrogen and bromocriptine on in vivo secretion and mitosis in prolactin cells. Nature (Lond) 255:497-498.
7. 7. Carrillo AJ, Pool TB, Sharp ZD (1985) Vasoactive intestinal peptide increases prolactin messenger ribonucleic acid content in GH3 cells. Endocrinology 116:202-206.
8. 8. Onali P, Schwartz JP, Costa E (1981) Dopaminergic modulation of adenylate cyclase stimulation by vasoactive intestinal peptide in anterior pituitary. Proc Natl Acad Sci USA 78:6531-6534.
9. 9. Caron MG, Beaulieu M, Raymond V, Gagne B, Drouin J, Lefkowitz R, Labrie F (1978) Dopaminergic receptors in the anterior pituitary gland. J Biol Chem 253:2244-2253.
10. 10. Bunzow JR, Van Tol HH, Grandy DK, Albert P, Salon J, Christie M, Machida C A, Neve K A, Civelli O (1988) Cloning and expression of a rat D2 dopamine receptor cDNA. Nature 336:783-787.
11. 11. Dal Toso R, Sommer B, Ewert M, Herb A, Prichett DB, Bach A, Shivers BD, and Seeburg PH (1989) The dopamine D2 receptor: two molecular forms generated by alternative splicing. EMBO 8:4025-4034.
12. 12. Sibley DR, Monsma FJ Jr (1993) Molecular biology of dopamine receptors. Trends Pharmacol Sci 13:61-69.
13. 13. Enjalbert A, Bockaert J (1983) Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary. Mol Pharmacol 23:576-584.
14. 2+ currents in rat anterior pituitary cells. Neuron 8:455-463.
15. 15. Montmayeur J-P, Guiramand J, Borrelli E (1993) Preferential coupling between dopamine D2 receptors and G-proteins. Mol Endocrinol 7:161-170.
16. 16. Senogles SE, Spiegel AM, Padrel E, Iyengar R, Caron MG (1990) Specificity of receptor-G protein interactions. J Biol Chem 265:4507-4515.
17. 17. De Camili P, Maconi D, Spada A (1979) Dopamine inhibits adenylyl cyclase in human prolactin-secreting adenomas. Nature (Lond) 278:252-254.
18. 18. Albert PR, Neve KA, Bunzow JR, Civelli O (1990) Coupling of a cloned rat dopamine-D2 receptor to inhibition of adenylyl cyclase and prolactin secretion. J Biol Chem 265:2098-2104.
19. 19. Elsholtz HP, Lew AM, Albert PR, Sundmark VC (1991) Inhibitory control of prolactin and Pit-1 gene promoter by dopamine. J Biol Chem 266:22919-22925.
20. 20. Iverson RA, Day KH, d'Emden M, Day RN, Maurer RA (1990) Clustered point mutation analysis of the rat prolactin promoter. Mol Endocrinol 4:1564-1571.
21. 21. Peers B, Monget P, Nalda MA, Voz M, Berwaer M, Belayew B, Martial JA (1991) Transcription induction of the human prolactin gene by cAMP requires two cis-acting elements and at least the pituitary specific factor pit-1. J Biol Chem 266:18127-18134.
22. 22. Keech AK, Jackson SM, Siddiqui SK, Ocran KW, Guttierrez-Hartman A (1992) Cyclic adenosine 3′,5′-monophosphate activation of the rat prolactin promoter is restricted to the pituitary-specific cell type. Mol. Endocrinol. 6:2059-2070.
23. 23. Day RN, Walder JA, Maurer RA (1989) A protein kinase inhibitor gene reduces both basal and multi hormone-stimulated prolactin gene transcription. J Biol Chem 264:431-436.
24. 24. Sarkar DK, Kim KH, Minami S (1992) Transforming growth factor-β1 messenger RNA and protein expression in the pituitary gland: its action on prolactin secretion and lactotropic growth. Mol Endocrinol 6:1825-1833.
25. 25. Burns G, Sarkar DK (1993) Transforming growth factor-β1-like immunoreactivity in the pituitary gland on the rat: effect of estrogen. Endocrinology 133:1444-1449.
26. 26. Pastorcic M, De A, Boyadjieva N, Vale W, Sarkar DK (1995) Reduced transforming growth factor β1 expression and function in the lactotropes during estrogen-induced tumorigenesis. Cancer Res 55:4892-4898.
27. 27. Lalli E, Sassone-Corsi P (1994) Signal transduction and gene regulation: the nuclear response to cAMP. J Biol Chem 269:17359-17362.
28. 28. Borrelli E, Montmayeur JP, Foulkes NS, Sassone-Corsi P (1992) Signal transduction and gene control: the cAMP pathway. Crit Rev Oncogen 3:321-338.
29. 29. Hunter T, Karin M (1992) The regulation of transcription by phosphorylation. Cell 70:375-387.
30. 30. Kim S-J, Glick A, Sporn MB, Roberts AB (1989) Characterization of the promoter region of the human transforming growth factor-b1 gene. J Biol Chem 264:402-408.
31. 31. Geiser AG, Kim S-J, Roberts AB, Sporn MB (1991) Characterization of the mouse transforming growth factor-β1 promoter and activation by the Ha-ras oncogene. Mol Cell Biol 11:84-92.
32. 32. Kim S-J, Angel P, Lafyatis R, Hatori K, Kim KY, Sporn MB, Karin, M, Roberts AB (1990) Autoinduction of transforming growth factor β1 is mediated by the AP-1 complex. Mol Cell Biol 10:1492-1497.
33. 33. Coleman DT, Bancroft C (1993) Pituitary adenylate cyclase stimulating peptide stimulates prolactin gene expression in a rat pituitary cell line. Endocrinology 133:2737-2741.
34. 34. Porter TE, Grandy D, Bunzow J, Wiles CD, Civelli O, Frawley LS (1994) Evidence that stimulatory dopamine receptors may be involved in the regulation of prolactin secretion. Endocrinology 134:1263-1268.
35. 35. Hille B (1992) G protein-coupled mechanisms and nervous signaling. Cell 9:187-195.
36. 36. Pastorcic M, Sarkar DK (1994) Evidence that both transforming growth factor β1 and transforming growth factor β3 are present in the pituitary lactotropes and control lactotropic function. Proc Soc Endocr Ann Meet 76:1379.
37. 37. Roberts AB, Sporn MB (1990) Peptide growth factors and their receptors. In Sporn MB, Roberts AB (eds) Handbook of Experimental Pharmacology Vol. 95, Springer-Verlag, Heildelberg, pp. 419-472.
38. 38. Chomczynski P, Sacchi N (1987) Single step method for RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
39. 39. Blum M (1989) Regulation of neuroendocrine peptide gene expression. Methods Enzymol 168:618-633.